Nephrology News
Cytoreductive Nephrectomy May Up Survival in Papillary mRCC
Study reveals a 38% decreased risk of death in patients with papillary metastatic renal cell carcinoma who undergo cytoreductive nephrectomy vs those who do not.
By accepting you will be accessing a service provided by a third-party external to https://galencarepartners.com/